Bristol-based biotech company Mykor has raised £4 million in a funding round led by Clean Growth Fund, with participation from the British Business Bank’s South West Investment Fund via The FSE Group, Green Angel Ventures, and Innovate UK’s investor partnership programme, bringing its total funding to £7.5 million.
- Founded in 2020 by Olivia Page and Valentina Dipietro, Mykor develops low-carbon construction materials made from agricultural and industrial waste using mycelium-based biotechnology.
- The company produces insulated wall systems and loose-fill insulation designed to replace conventional high-carbon materials such as polystyrene and masonry insulation.
- Its manufacturing process combines engineered fungal strains, green chemistry additives and automated production systems to convert biomass waste into fire-resistant, thermal and acoustic building products that can be integrated into existing construction supply chains.
Details of the deal
- Mykor plans to use the £4 million funding to scale production of its low-carbon construction systems, expand manufacturing through existing industrial partners, and grow deployment across UK and European markets. The company aims to help developers reduce both embodied and operational carbon in buildings using biofabricated materials made from agricultural and industrial waste.
“We’re delighted to provide this investment from the South West Investment Fund to support genuinely breakthrough materials science in the delivery of meaningful carbon reductions," explains Anna Staevska, Investment Manager at The FSE Group.
